Leprosy

• FDA label_change · 2013-06-27
  FDA Approved: RIFAMPIN — Supplemental Application (Chartwell RX, LLC)

  The FDA approved a supplemental application for Rifampin filed by Chartwell RX, LLC, leading to changes in the product labeling.

• CLINICAL_TRIALS research · 2011-06-23
  Clinical Trial Update: Molecular Epidemiology of Leprosy - Philippines

  This entry reports the completion of a clinical trial studying the molecular epidemiology of leprosy in the Philippines.

• CLINICAL_TRIALS trial_result · 2010-11-01
  Clinical Trial Update: Leprosy Skin Test Antigens Trial [Phase 2]

  Phase 2 clinical trial evaluating leprosy skin test antigens has completed, with results posted in 2010.

• CLINICAL_TRIALS trial_result · 2009-12-15
  Clinical Trial Update: The Use of Low Level Laser Therapy for Wound Healing in Leprosy Patients [NA]

  The clinical trial evaluating low-level laser therapy for wound healing in leprosy patients has completed.

• CLINICAL_TRIALS guidance · 2009-11-03
  Clinical Trial Update: Prevention of Disability: Proposal for a Guidance Manual for Leprosy Patients [Phase 1]

  Phase 1 trial update focused on developing a guidance manual to prevent disability in leprosy patients. The study—sponsored by the Universit…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2008-05-22
  FDA Approved: RIFAMPIN — Original Application (Mylan Institutional LLC)

  FDA approved an Original Application for rifampin from Mylan Institutional LLC, enabling a generic rifampin product. This action approves th…

• FDA approval · 2008-03-28
  FDA Approved: RIFAMPIN — Original Application (Chartwell RX, LLC)

  FDA approved an Original Application (ANDA) for rifampin submitted by Chartwell RX, LLC. This marks approval of a generic rifampin product.

• CLINICAL_TRIALS research · 2006-12-04
  Clinical Trial Update: Montelukast in ENL Reaction [NA]

  Clinical trial update on montelukast for erythema nodosum leprosum and leprosy with unknown trial status.